These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 33618862)
21. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Ho DM; Hsu CY; Ting LT; Chiang H Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512 [TBL] [Abstract][Full Text] [Related]
22. Atypical and malignant meningiomas: a clinicopathological review. Mahmood A; Caccamo DV; Tomecek FJ; Malik GM Neurosurgery; 1993 Dec; 33(6):955-63. PubMed ID: 8134008 [TBL] [Abstract][Full Text] [Related]
23. A radiopathological classification of dural tail sign of meningiomas. Qi ST; Liu Y; Pan J; Chotai S; Fang LX J Neurosurg; 2012 Oct; 117(4):645-53. PubMed ID: 22839654 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients. Perry A; Chicoine MR; Filiput E; Miller JP; Cross DT Cancer; 2001 Aug; 92(3):701-11. PubMed ID: 11505418 [TBL] [Abstract][Full Text] [Related]
25. Crush preparations of meningiomas: can grading be accomplished? Ali S; Nassar A; Siddiqui MT Diagn Cytopathol; 2008 Nov; 36(11):827-31. PubMed ID: 18831022 [TBL] [Abstract][Full Text] [Related]
26. The role of three-dimensional pseudo-continuous arterial spin labelling in grading and differentiating histological subgroups of meningiomas. Lu Y; Xiong J; Yin B; Wen J; Liu L; Geng D Clin Radiol; 2018 Feb; 73(2):176-184. PubMed ID: 29031810 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806 [TBL] [Abstract][Full Text] [Related]
28. A conceptual shift in the grading of meningiomas. Lohmann CM; Brat DJ Adv Anat Pathol; 2000 May; 7(3):153-7. PubMed ID: 10809221 [TBL] [Abstract][Full Text] [Related]
30. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689 [TBL] [Abstract][Full Text] [Related]
31. Accuracy of frozen section in determining meningioma subtype and grade. Prayson RA Ann Diagn Pathol; 2018 Aug; 35():7-10. PubMed ID: 30072016 [TBL] [Abstract][Full Text] [Related]
32. Pathology of meningiomas. Solomon DA; Pekmezci M Handb Clin Neurol; 2020; 169():87-99. PubMed ID: 32553300 [TBL] [Abstract][Full Text] [Related]
33. Pathologic Predictors of Local Recurrence in Atypical Meningiomas Following Gross Total Resection. Barrett OC; Hackney JR; McDonald AM; Willey CD; Bredel M; Fiveash JB Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):453-459. PubMed ID: 30253235 [TBL] [Abstract][Full Text] [Related]
34. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study. Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240 [TBL] [Abstract][Full Text] [Related]
35. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas. Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539 [TBL] [Abstract][Full Text] [Related]
36. Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases. Picart T; Dumot C; Guyotat J; Pavlov V; Streichenberger N; Vasiljevic A; Fenouil T; Durand A; Jouanneau E; Ducray F; Jacquesson T; Berhouma M; Meyronet D Neurosurg Rev; 2022 Aug; 45(4):2797-2809. PubMed ID: 35488071 [TBL] [Abstract][Full Text] [Related]
37. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619 [TBL] [Abstract][Full Text] [Related]
38. Brain invasion in meningiomas: does surgical sampling impact specimen characteristics and histology? Timme M; Thomas C; Spille DC; Stummer W; Ebel H; Ewelt C; Hans FJ; Schick U; Puchner M; Wildförster U; Bruns B; Trost HA; Holling M; Grauer O; Hess K; Brokinkel B Neurosurg Rev; 2020 Apr; 43(2):793-800. PubMed ID: 31161444 [TBL] [Abstract][Full Text] [Related]
39. Correlation of volumetric growth and histological grade in 50 meningiomas. Soon WC; Fountain DM; Koczyk K; Abdulla M; Giri S; Allinson K; Matys T; Guilfoyle MR; Kirollos RW; Santarius T Acta Neurochir (Wien); 2017 Nov; 159(11):2169-2177. PubMed ID: 28791500 [TBL] [Abstract][Full Text] [Related]
40. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies. Puripat N; Loharamtaweethong K Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]